本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

爵士製藥

110.80
+1.821.67%
盤前109.85-0.9500-0.86%04:41 EDT
成交量:89.63萬
成交額:9,883.37萬
市值:67.29億
市盈率:12.81
高:111.17
開:108.52
低:107.66
收:108.98
資料載入中...

公司資料

公司名字:
爵士製藥
交易所:
NASDAQ
成立時間:
2003
員工人數:
2800
公司地址:
Waterloo Exchange,Fifth Floor,Waterloo Road,Dublin 4,Dublin,Co. Dublin,Ireland
郵編:
D04 E5W7
傳真:
- -
簡介:
Jazz Pharmaceuticals Public Limited Company是一家公眾有限責任公司,根據愛爾蘭法律於2005年3月成立。爵士製藥公司是一家專業製藥公司,專註於醫藥產品的識別、開發和商業化,以滿足巨大的醫療需求。 自2003年建立以來,它已經建立了一個商業和發展組織,組裝的產品和候選產品目前包括兩種在售產品,以及正處在臨床開發的各個階段的候選產品。它目前銷售兩種產品: Xyrem (羥丁酸鈉) ,這是經美國食品和藥物管理局(FDA)唯一批準的治療嗜睡引起的猝倒證和白天過度嗜睡的產品;蘭釋CR (馬來酸氟伏沙明)用於強迫症的治療。公司通過其經驗豐富的專業銷售隊伍:睡眠專家、神經病學家、肺科和精神科醫生促進這些產品在美國銷售。

董事

名稱
職位
Bruce C. Cozadd
Chairperson and Chief Executive Officer
Anne O'Riordan
Independent Director
Catherine A. Sohn
Independent Director
Heather Ann McSharry
Independent Director
Jennifer E. Cook
Independent Director
Kenneth W. O'Keefe
Independent Director
Mark D. Smith
Independent Director
Norbert G. Riedel
Independent Director
Patrick G. Enright
Independent Director
Peter Gray
Independent Director
Rick E Winningham
Lead Independent Director
Seamus C. Mulligan
Independent Director

股東

名稱
職位
Bruce C. Cozadd
Chairperson and Chief Executive Officer
Daniel N. Swisher, Jr.
President, Chief Operating Officer
Finbar Larkin
Senior Vice President, Technical Operations
Patricia Carr
Senior Vice President, Chief Accounting Officer
Renee Gala
Executive Vice President and Chief Financial Officer
Samantha Pearce
Senior Vice President, Europe and International
Kim Sablich
Executive Vice President and General Manager, US
Neena M. Patil
Executive Vice President and Chief Legal Officer
Robert Iannone
Executive Vice President, Global Head of Research and Development